Ph.D., EVP of Research & Development & CSO, Seres Therapeutics
David Cook is the EVP of R&D and CSO of Seres Therapeutics, Inc. He has over 20 years of experience as a scientist and entrepreneur and has held senior operating and management positions in the biotechnology industry throughout his career. Prior to joining Seres, he served as the COO for the International AIDS Vaccine Initiative. Prior to IAVI, Dr. Cook was the founding CEO at Anza Therapeutics. Before Anza he held positions of increasing responsibility at Cerus and Eligix. He earned his undergraduate degree from Harvard College and his Ph.D. from the University of California, Berkeley.
Microbiome Therapeutics in The Age of
Personalized DNA Sequence
The role of the microbiome in promoting health and disease in infectious disease, inflammation and metabolic disorders has been established clinically, yet there is no single state of microbiome health. The potential for individualized microbiome therapy to treat and prevent disease based on real-time microbiome sequence analysis will be discussed.